Issued on behalf of LIXTE Biotechnology Holdings, Inc.America can build data centers in months, but the electricity to run them can take half a ...
One of the most dramatic corporate reinventions of 2026 is taking a clinical-stage biotech and rebuilding it as a power-infrastructure company — aimed squarely at the electricity shortage throttling ...
As AI transforms biology, longevity startups are attracting investors, advancing toward clinical milestones, and reshaping ...
Fertility specialists, biotech companies and ethicists are divided over whether progress in early gene editing would wipe out ...
With a course offered this past spring semester, professors and students alike have begun grappling with the role automated ...
Tokyo, Japan and Cambridge, UK, 10 June 2026 – Nxera Pharma Co., Ltd. (“Nxera” or the “Company”) announces that it has joined OpenFold, a ...
Building on its legacy of standardizing LC separation, Evosep now extends upstream to sample preparation, delivering complete ...
In the highly regulated fields of pharmaceutical, bio-pharmaceuticals, medical devices, and clinical diagnostics, bacterial endotoxin testing (BET) remains a critical requirement for safeguarding ...
Two workforce development boards in Central Texas are among a handful in the state receiving grants from the Texas Workforce ...
By another count, 78 of the 860 life sciences companies in NCBiotech’s company directory include AI or machine learning in ...
A life sciences development site in Emeryville traded at a steep discount, underscoring how far the East Bay’s biotech boom has fallen. An entity tied to Graymark Capital bought the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results